CYCC icon

Cyclacel Pharmaceuticals
CYCC

Overview Fund Activity

2 hedge funds and large institutions have $7.5M invested in Cyclacel Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$137K
Puts
$44K
Net Calls
+$93K
Net Calls Change
-$109K

Top Buyers

No buyers this quarter

Top Sellers

1
IHM
1
Iguana Healthcare Management
New York
$920K
2
Goldman Sachs
2
Goldman Sachs
New York
$485K
3
IPC
3
Invesco Private Capital
New York
$428K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$262K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$262K
Name Holding Trade Value Shares
Change 		Shares
Change %
VKH
26
Virtu KCG Holdings
New York
– -$153K – –
Jane Street
27
Jane Street
New York
– -$54K – –
Millennium Management
28
Millennium Management
New York
– -$45K – –
CS
29
Credit Suisse
Switzerland
– -$114K – –
California Public Employees Retirement System
30
California Public Employees Retirement System
California
– -$29K – –
1
2